Literature DB >> 29563341

Active epithelial Hippo signaling in idiopathic pulmonary fibrosis.

Jason J Gokey1, Anusha Sridharan1, Yan Xu2, Jenna Green1, Gianni Carraro3, Barry R Stripp3, Anne-Karina T Perl1, Jeffrey A Whitsett1.   

Abstract

Hippo/YAP signaling plays pleiotropic roles in the regulation of cell proliferation and differentiation during organogenesis and tissue repair. Herein we demonstrate increased YAP activity in respiratory epithelial cells in lungs of patients with idiopathic pulmonary fibrosis (IPF), a common, lethal form of interstitial lung disease (ILD). Immunofluorescence staining in IPF epithelial cells demonstrated increased nuclear YAP and loss of MST1/2. Bioinformatic analyses of epithelial cell RNA profiles predicted increased activity of YAP and increased canonical mTOR/PI3K/AKT signaling in IPF. Phospho-S6 (p-S6) and p-PTEN were increased in IPF epithelial cells, consistent with activation of mTOR signaling. Expression of YAP (S127A), a constitutively active form of YAP, in human bronchial epithelial cells (HBEC3s) increased p-S6 and p-PI3K, cell proliferation and migration, processes that were inhibited by the YAP-TEAD inhibitor verteporfin. Activation of p-S6 was required for enhancing and stabilizing YAP, and the p-S6 inhibitor temsirolimus blocked nuclear YAP localization and suppressed expression of YAP target genes CTGF, AXL, and AJUBA (JUB). YAP and mTOR/p-S6 signaling pathways interact to induce cell proliferation and migration, and inhibit epithelial cell differentiation that may contribute to the pathogenesis of IPF.

Entities:  

Keywords:  Cell Biology; Pulmonary surfactants; Pulmonology

Mesh:

Substances:

Year:  2018        PMID: 29563341      PMCID: PMC5926907          DOI: 10.1172/jci.insight.98738

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  48 in total

1.  A mutation in the surfactant protein C gene associated with familial interstitial lung disease.

Authors:  L M Nogee; A E Dunbar; S E Wert; F Askin; A Hamvas; J A Whitsett
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

2.  Dual function of Yap in the regulation of lens progenitor cells and cellular polarity.

Authors:  Ji Yun Song; Raehee Park; Jin Young Kim; Lucinda Hughes; Li Lu; Seonhee Kim; Randy L Johnson; Seo-Hee Cho
Journal:  Dev Biol       Date:  2013-12-31       Impact factor: 3.582

Review 3.  The Hippo Pathway: A Master Regulatory Network Important in Development and Dysregulated in Disease.

Authors:  Cathie M Pfleger
Journal:  Curr Top Dev Biol       Date:  2017-01-19       Impact factor: 4.897

4.  The Hippo-YAP signaling pathway and contact inhibition of growth.

Authors:  Barry M Gumbiner; Nam-Gyun Kim
Journal:  J Cell Sci       Date:  2014-02-15       Impact factor: 5.285

Review 5.  The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.

Authors:  Xaralabos Varelas
Journal:  Development       Date:  2014-04       Impact factor: 6.868

Review 6.  Diseases of pulmonary surfactant homeostasis.

Authors:  Jeffrey A Whitsett; Susan E Wert; Timothy E Weaver
Journal:  Annu Rev Pathol       Date:  2015       Impact factor: 23.472

7.  Ajuba LIM proteins are negative regulators of the Hippo signaling pathway.

Authors:  Meghna Das Thakur; Yunfeng Feng; Radhika Jagannathan; Midori J Seppa; James B Skeath; Gregory D Longmore
Journal:  Curr Biol       Date:  2010-03-18       Impact factor: 10.834

8.  Crumbs3-Mediated Polarity Directs Airway Epithelial Cell Fate through the Hippo Pathway Effector Yap.

Authors:  Aleksander D Szymaniak; John E Mahoney; Wellington V Cardoso; Xaralabos Varelas
Journal:  Dev Cell       Date:  2015-07-30       Impact factor: 12.270

9.  YAP is essential for mechanical force production and epithelial cell proliferation during lung branching morphogenesis.

Authors:  Chuwen Lin; Erica Yao; Kuan Zhang; Xuan Jiang; Stacey Croll; Katherine Thompson-Peer; Pao-Tien Chuang
Journal:  Elife       Date:  2017-03-21       Impact factor: 8.140

10.  The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium.

Authors:  Max A Seibold; Russell W Smith; Cydney Urbanek; Steve D Groshong; Gregory P Cosgrove; Kevin K Brown; Marvin I Schwarz; David A Schwartz; Susan D Reynolds
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

View more
  44 in total

1.  TAZ is required for lung alveolar epithelial cell differentiation after injury.

Authors:  Tianhe Sun; Zhiyu Huang; Hua Zhang; Clara Posner; Guiquan Jia; Thirumalai R Ramalingam; Min Xu; Hans Brightbill; Jackson G Egen; Anwesha Dey; Joseph R Arron
Journal:  JCI Insight       Date:  2019-06-18

Review 2.  New therapeutics based on emerging concepts in pulmonary fibrosis.

Authors:  Vishwaraj Sontake; Prathibha R Gajjala; Rajesh K Kasam; Satish K Madala
Journal:  Expert Opin Ther Targets       Date:  2018-11-28       Impact factor: 6.902

3.  Role of the autotaxin-lysophosphatidic acid axis in glaucoma, aqueous humor drainage and fibrogenic activity.

Authors:  Leona T Y Ho; Anja Osterwald; Iris Ruf; Daniel Hunziker; Patrizio Mattei; Pratap Challa; Robin Vann; Christoph Ullmer; Ponugoti Vasanth Rao
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-10-21       Impact factor: 5.187

Review 4.  Stiffness Sensing by Cells.

Authors:  Paul A Janmey; Daniel A Fletcher; Cynthia A Reinhart-King
Journal:  Physiol Rev       Date:  2019-11-21       Impact factor: 37.312

5.  YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF.

Authors:  Yingzhun Chen; Xiaoguang Zhao; Jian Sun; Wei Su; Lu Zhang; Yingnan Li; Yingqi Liu; Lijia Zhang; Yanjie Lu; Hongli Shan; Haihai Liang
Journal:  Cell Death Differ       Date:  2019-01-15       Impact factor: 15.828

6.  ARHGEF7 (β-PIX) Is Required for the Maintenance of Podocyte Architecture and Glomerular Function.

Authors:  Jun Matsuda; Mirela Maier; Lamine Aoudjit; Cindy Baldwin; Tomoko Takano
Journal:  J Am Soc Nephrol       Date:  2020-03-18       Impact factor: 10.121

7.  MEG3 is increased in idiopathic pulmonary fibrosis and regulates epithelial cell differentiation.

Authors:  Jason J Gokey; John Snowball; Anusha Sridharan; Joseph P Speth; Katharine E Black; Lida P Hariri; Anne-Karina T Perl; Yan Xu; Jeffrey A Whitsett
Journal:  JCI Insight       Date:  2018-09-06

8.  Network Pharmacology-Based Mechanistic Investigation of Jinshui Huanxian Formula Acting on Idiopathic Pulmonary Fibrosis.

Authors:  Tiantian Liu; Pengli Xu; Shuishui Qi; Shaorui Ke; Qin Hu; Peng Zhao; Jiansheng Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-07       Impact factor: 2.629

Review 9.  Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution.

Authors:  Anna Valeria Samarelli; Roberto Tonelli; Irene Heijink; Aina Martin Medina; Alessandro Marchioni; Giulia Bruzzi; Ivana Castaniere; Dario Andrisani; Filippo Gozzi; Linda Manicardi; Antonio Moretti; Stefania Cerri; Riccardo Fantini; Luca Tabbì; Chiara Nani; Ilenia Mastrolia; Daniel J Weiss; Massimo Dominici; Enrico Clini
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

Review 10.  Noncanonical Wnt planar cell polarity signaling in lung development and disease.

Authors:  Eszter K Vladar; Melanie Königshoff
Journal:  Biochem Soc Trans       Date:  2020-02-28       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.